Likewise, CXCL5 is overexpressed in ccRCC [33, 34], and based on its involvement in angiogenesis, tumor growth, and metastasis [35] has been deemed an important biomarker and a critical adjunct antiangiogenic therapy target [34]. The gene discussed is CXCL5; the disease is nonpapillary renal cell carcinoma.